As IBM prepares to release its first-quarter 2026 results after the US market close today, the technology giant finds itself at a crossroads. Investors are weighing two powerful, opposing forces: the promise of growth from its software and infrastructure units against significant threats to its legacy consulting business and the immediate costs of a major acquisition.
The market’s nervousness is palpable in the stock’s performance. Trading recently at 218.80 euros, IBM shares have fallen roughly 13% since the start of the year. A single-day plunge of 13% in late February marked the stock’s worst daily drop in nearly a quarter-century. That sell-off was triggered by AI startup Anthropic, which claimed its new tool could modernize outdated COBOL code—a direct challenge to IBM’s lucrative mainframe ecosystem where such legacy applications are common.
Software Strength and Acquisition Impact
Wall Street expects the company to report robust headline figures for Q1. Consensus estimates point to revenue of $15.6 billion and earnings per share of $1.81, a solid increase from the $1.60 reported a year earlier. The software division, bolstered by Red Hat and the recent acquisition of data-streaming platform Confluent, is seen as the primary growth engine. Analyst Brent Thill of Jefferies views IBM as an undervalued AI beneficiary and anticipates software performance exceeding market expectations.
The Confluent deal, finalized in March, is a key focal point. Bank of America analyst Wamsi Mohan projects it will contribute approximately $50 million in revenue. However, the early closing brings near-term financial headwinds. Analysts have subsequently trimmed their full-year 2026 EPS estimates to $11.98, citing dilution from the acquisition and ongoing softness in consulting.
Consulting Weakness and Infrastructure Support
Should investors sell immediately? Or is it worth buying IBM?
The consulting segment remains a sore spot, having grown by just 1% in the final quarter of 2025. The rise of AI-powered programming tools poses a growing threat to this labor-intensive core service. While IBM management has pushed back against Anthropic’s claims—arguing that code translation is the easy part compared to data architecture redesign and hardware integration—investor concern persists.
Offsetting this weakness, the infrastructure business is forecast to be a pillar of strength. Bank of America predicts roughly 24% revenue growth for the division, driven by the new z17 mainframe cycle. This hardware resilience is critical as the company seeks to prove that demand for its AI platform, watsonx, can counterbalance traditional consulting challenges.
Dividend Tradition and Cash Flow
Income-focused investors await news on IBM’s legendary dividend. The company has paid consecutive dividends since 1916 and raised them annually for over three decades. Analysts anticipate an increase in the quarterly payout to about $1.69 per share, a move supported by strong cash generation. IBM generated substantial free cash flow last year and is targeting approximately $15.7 billion for 2026.
The analyst community maintains a cautiously optimistic stance, though several firms have recently lowered price targets while reaffirming buy ratings:
– Jefferies: “Buy,” target reduced from $370 to $320
– RBC Capital: “Outperform,” target cut from $361 to $330
– Oppenheimer: “Outperform,” target lowered from $380 to $320
– Stifel: “Buy,” target adjusted down from $340 to $290
Today’s report serves as the first major test of management’s forecast for mid-single-digit currency-adjusted revenue growth in 2026. Concrete commentary on AI monetization and the consulting division’s trajectory will likely set the stock’s near-term direction.
Ad
IBM Stock: Buy or Sell?! New IBM Analysis from April 22 delivers the answer:
The latest IBM figures speak for themselves: Urgent action needed for IBM investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 22.
IBM: Buy or sell? Read more here...









